Inhibition of angiogenesis and the angiogenesis/invasion shift

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Antiangiogenic therapy: impact on invasion, disease progression and metastasis

(2011) John M. L. Ebos et al.   Nature Reviews Clinical Oncology

Functional divergence between 2 chemokines is conferred by single amino acid change

(2010) A. Dubrac et al.   BLOOD

Inositol-requiring enzyme 1  is a key regulator of angiogenesis and invasion in malignant glioma

(2010) G. Auf et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

New insights into the molecular interaction of the C-terminal sequence of CXCL4 with fibroblast growth factor-2

(2009) Laura Ragona et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy

(2009) J. M. L. Ebos et al.   CLINICAL CANCER RESEARCH

Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness

(2009) Ahlame Saidi et al.   INTERNATIONAL JOURNAL OF CANCER

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

(2009) G L Semenza   ONCOGENE

Chemokines as Mediators of Neovascularization

(2008) Ellen C. Keeley et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

How IRE1 Reacts to ER Stress

(2008) David Ron et al.   CELL

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE

The CXC-Chemokine CXCL4 Interacts with Integrins Implicated in Angiogenesis

(2008) Sallouha Aidoudi et al.   PLoS One